Grant

The HER2-RADiCAL study (Response ADaptive CAre pLan) - tailoring treatment for HER2 positive early breast cancer

NIHR131362

Status
active
Period

2021-06-012029-11-01

The HER2-RADiCAL study (Response ADaptive CAre pLan) - tailoring treatment for HER2 positive early breast cancer